Home

Home

Steep drop in breast cancer rates

Less hormone therapy plus less screening

USA – A steep drop in breast cancer rates between 2002 and 2003 correlates with the decline in hormone therapy use, according to research froma the American Cancer Society (ACS).

However, the researchers also point out that the decline might indicate that fewer instances were detected because mammogram screenings had levelled off. (Between 1980-98, when mammograms became more common, breast cancer rates rose fast and by almost 40%).

The greatest decline in rates was among women 50-69 years old – those most likely to receive hormone therapy. However, the researchers say that stopping hormone therapy cannot explain their other major finding: breast cancer rates started to drop in 1999, for all women 45 and above, well before the link between hormone therapy and health problems was discovered. They reason that the most likely explanation for this earlier decline is, after almost 12 years of increase, mammography use levelled off during those years. 

The ACS also believes that part of the decline in breast cancer cases might be temporary, which would mean there has been a delay in detection, rather than an actual decrease in incidence.

This article was published on 06/20/2007

Search

 

Service

Company News

Meet us at MEDICA! Hall 7 Stand 15

The European Hospital team will be happy to hear about your research, products, R&D or trials and launches, hospital management issues, or any other aspects of your work, so that we can discuss your editorial ideas. We will also be pleased to help with any PR or advertising queries.

Products redesigned to help patients simplify life with diabetes

Bayer HealthCare Diabetes Care unveiled the new
CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.

Technical infrastructure for EU funded R-bay project

Carestream Health is a major technical infrastructure provider to the EU-funded R-Bay validation project, which aims to address the uneven spread of radiologists across member states. CARESTREAM Radiology and Information Management Solutions are driving the initial test platform for the project by facilitating remote reporting of images from hospitals in Denmark, Finland and Czech Republic by clinical providers in Estonia, Lithuania and the Netherlands.